Paper41999458
Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels.
Debuysschere C and 6 others. Immunol Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels. Papers, record 41999458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoantibodies | Major topic |
| Glutamate Decarboxylase | Major topic |
| Herpesvirus 4, Human | Major topic |
| Epstein-Barr Virus Infections | Major topic |
| Islets of Langerhans | Major topic |
| Autoimmune Diseases | Major topic |
| Humans | |
| Female | |
| Adolescent | |
| Male | |
| Child | |
| Child, Preschool | |
| Adult | |
| Young Adult | |
| Antibodies, Viral | |
| Autoimmunity | |
| Immunoglobulin G | |
| Antigens, Viral |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33488588 | Epstein-Barr Virus and Systemic Autoimmune Diseases. | Front Immunol | 2020 | https://conductscience.org/library/papers/33488588 | PubMed |
| 2 | 36305070 | Discussion on regression analysis with small determination coefficient in human-environment researches. | Indoor Air | 2022 | https://conductscience.org/library/papers/36305070 | PubMed |
| 3 | 35025605 | Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. | Science | 2022 | https://conductscience.org/library/papers/35025605 | PubMed |
| 4 | 15037992 | Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. | Diabetes Metab Res Rev | 2004 | https://conductscience.org/library/papers/15037992 | PubMed |
| 5 | 39390260 | Epstein-Barr virus as a potentiator of autoimmune diseases. | Nat Rev Rheumatol | 2024 | https://conductscience.org/library/papers/39390260 | PubMed |
| 6 | 39286141 | EBNA-1 antibody and autoimmune rheumatic diseases: A Mendelian Randomization Study. | Heliyon | 2024 | https://conductscience.org/library/papers/39286141 | PubMed |
| 7 | 29916386 | Type 1 diabetes. | Lancet | 2018 | https://conductscience.org/library/papers/29916386 | PubMed |
| 8 | 11416235 | Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients. | Horm Res | 2000 | https://conductscience.org/library/papers/11416235 | PubMed |
| 9 | 37317236 | Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis. | Microorganisms | 2023 | https://conductscience.org/library/papers/37317236 | PubMed |
| 10 | 22951828 | Persistence of Epstein-Barr virus in self-reactive memory B cells. | J Virol | 2012 | https://conductscience.org/library/papers/22951828 | PubMed |
| 11 | 37699205 | Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes. | Diabetes Care | 2023 | https://conductscience.org/library/papers/37699205 | PubMed |
| 12 | 26450993 | Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. | Diabetes | 2016 | https://conductscience.org/library/papers/26450993 | PubMed |
| 13 | 1645169 | Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. | APMIS | 1991 | https://conductscience.org/library/papers/1645169 | PubMed |
| 14 | 40284570 | Evolution of Epstein-Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013-2023. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284570 | PubMed |
| 15 | 34614253 | Persistence of islet autoantibodies after diagnosis in type 1 diabetes. | Diabet Med | 2021 | https://conductscience.org/library/papers/34614253 | PubMed |
| 16 | 19107979 | Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern. | J Med Virol | 2009 | https://conductscience.org/library/papers/19107979 | PubMed |
| 17 | 18789535 | Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile. | J Infect | 2008 | https://conductscience.org/library/papers/18789535 | PubMed |
| 18 | 35931816 | Epstein-Barr virus and multiple sclerosis. | Nat Rev Microbiol | 2023 | https://conductscience.org/library/papers/35931816 | PubMed |
| 19 | 39662065 | ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. | Horm Res Paediatr | 2024 | https://conductscience.org/library/papers/39662065 | PubMed |
| 20 | 29327148 | Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes. | Acta Diabetol | 2018 | https://conductscience.org/library/papers/29327148 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41999458
GET https://conductscience.org/api/papers/v1/41999458/authors